Forbes reporter covering science and medicine
Long-Ago Twist Yields Ballmer A Fortune In Microsoft Stock #forbesmagazine onforb.es/1wUBIqu by @GeorgeAnders + THAT PICTURE
RT @ddiamond: Brace for a new wave of insurance plan cancellations, including 14,000 canceled Humana plans in KY. @MeghanMcCarthy_: bit.ly/1tenFs5
@iddux Nope. Disagree. Look, we could probably have a really cool conversation about this, but right now, we're not. Another time?
RT @AndyBiotech: NantHealth Completes $320M Series B and Expands Leadership Team
@matthewherper recent story
RT @marynmck: more on Ebola infection prevention: @eliowa on “moon suits” = overkill (see also his plea re IP research funding) haicontroversies.blogspot.com/2014/09/overpr…
Just... need... to... call... one... more... source... <falls asleep.> pic.twitter.com/rPCpwesRDv
RT @lizzieohreally: Why there is no Ebola vaccine: marketplace.org/topics/health-… (money).
RT @Laurie_Garrett: Detailed @WHO case breakdown on #Ebola in #Liberia #SierraLeone #Guinea, grossly underreported apps.who.int/iris/bitstream… pic.twitter.com/GjEDl5zGwI
@MartinShkreli You should change your twitter bio.
RT @adamfeuerstein: $VTUS, last seen developing drugs to soothe irritated assholes (literally), has a new name $ASMB and new focus — HepB.
Learn how to connect with Matthew on social
media by joining Muck Rack Pro
Create a free Muck Rack account to customize your profile and upload a portfolio of your